Dodgers Bullpen in Crisis: What’s Next After Graterol's Surgery? 

The news of Brusdar Graterol's shoulder surgery and his expected absence for the first half of the 2025 season raises some intriguing questions about the future of the Dodgers' pitching staff. With Graterol's injury history and the already depleted rotation, how should the Dodgers approach their offseason strategy?

Could this be the moment they pivot towards a more aggressive pursuit of free-agent pitchers? With names like Clayton Kershaw and Jack Flaherty potentially on the market, will the Dodgers prioritize experience or take a chance on younger, less proven arms?

Moreover, Graterol's situation brings to light the broader issue of how teams manage pitchers' health in today's game. Are we seeing a trend where teams are more willing to let pitchers undergo surgeries rather than risk further injury?

Let’s not forget the impact on Graterol himself. After a season where he barely pitched, how will this surgery affect his career trajectory? Will he be able to reclaim his spot as a key bullpen piece, or is this the beginning of a downward spiral for a once-promising talent?

What are your thoughts? How should the Dodgers navigate this challenging situation? And what does this mean for the future of pitching in MLB? Share your insights and predictions!